PagrindinisRHHBY • OTCMKTS
add
F. Hoffmann-La Roche
35,44 $
Uždarius biržą:(0,00 %)0,00
35,44 $
Uždaryta: 11-22, 16:46:30 GMT−5 · USD · OTCMKTS · Atsisakymas
Ankstesnė uždarymo kaina
35,29 $
Dienos intervalas
35,39 $ - 35,64 $
Metų intervalas
29,20 $ - 42,43 $
Bendroji vertė rinkoje
233,72 mlrd. USD
Vidutinė prekybos apimtis
1,15 mln.
Aktualios naujienos
Finansiniai rodikliai
Pajamų ataskaita
Pajamos
Grynosios pajamos
| (CHF) | 2024-06info | Metinis pokytis |
|---|---|---|
Pajamos | 15,38 mlrd. | 0,46 % |
Veiklos sąnaudos | 6,22 mlrd. | 0,75 % |
Grynosios pajamos | 3,13 mlrd. | −12,32 % |
Grynojo pelno marža | 20,35 | −12,70 % |
Pelnas tenkantis vienai akcijai | — | — |
EBITDA | 6,17 mlrd. | 1,01 % |
Taikomas mokesčio tarifas | 18,56 % | — |
Balansas
Visas turtas
Visi įsipareigojimai
| (CHF) | 2024-06info | Metinis pokytis |
|---|---|---|
Lėšos, trump. investicijos | 8,81 mlrd. | 17,38 % |
Visas turtas | 95,79 mlrd. | 13,53 % |
Visi įsipareigojimai | 62,91 mlrd. | 16,44 % |
Visos paprastosios akcijos | 32,88 mlrd. | — |
Išleistos akcijos | 796,79 mln. | — |
Kaina / apskaitinė vertė | 0,97 | — |
Turto grąža | 14,16 % | — |
Kapitalo grąža | 19,64 % | — |
Pinigų srautas
Grynasis pokytis (grynaisiais pinigais)
| (CHF) | 2024-06info | Metinis pokytis |
|---|---|---|
Grynosios pajamos | 3,13 mlrd. | −12,32 % |
Pinigai iš operacijų | 3,96 mlrd. | 0,20 % |
Pinigai iš investicijų | −1,43 mlrd. | −494,40 % |
Pinigai iš finansavimo | −2,72 mlrd. | 34,29 % |
Grynasis pokytis (grynaisiais pinigais) | −276,00 mln. | 56,57 % |
Laisvas pinigų srautas | 3,19 mlrd. | −2,82 % |
Apie
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. Roche is one of the few companies increasing their dividend every year, for 2020 as the 34th consecutive year.
F. Wikipedia
Generalinis direktorius
Įkurta
1896-10-01
Pagrindinė būstinė
Svetainė
Darbuotojų skaičius
103 605
